FDA Inspection 1265723 — Janssen Biotech, Inc.
The FDA completed an inspection of Janssen Biotech, Inc. on Mar 10, 2025 in Malvern, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 10, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Malvern, PA (United States)